Deciphera Pharmaceuticals, Inc. stock is up 1.26% since 30 days ago. The next earnings date is Feb 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 71.43% of the previous 6 November’s closed higher than October. In the last 2 Unusual Options Trades, there were 2 CALLs. 80% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
10 Oct 18:19 | 19 Jan, 2024 | 12.50 | 107 | ||
20 Oct 14:00 | 19 Jan, 2024 | 12.50 | 609 |
Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST)